The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Tumours associated with BAP1 mutations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Role of histone H2A ubiquitination in Polycomb silencing
Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R. S., & Zhang, Y. (2004) · Nature · doi:10.1038/nature02985 · Cited by 1,663
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Germline BAP1 Mutations Predispose to Malignant Mesothelioma
Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., Cox, N. J., Dogan, A. U., Pass, H. I., Trusa, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.912 · Cited by 1,076
BAP1 loss defines a new class of renal cell carcinoma
Peña-Llopis, S., Vega-Rubín-de-Celis, S., Liao, A., Leng, N., Pavía-Jiménez, A., Wang, S., Yamasaki, T., Zhrebker, L., Sivanand, S., Spence, P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2323 · Cited by 959
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
de Napoles, M., Mermoud, J. E., Wakao, R., Tang, Y. A., Endoh, M., Appanah, R., Nesterova, T. B., Silva, J., Otte, A. P., Vidal, M., et al. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.10.005 · Cited by 888
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Scheuermann, J. C., de Ayala Alonso, A. G., Oktaba, K., Ly-Hartig, N., McGinty, R. K., Fraterman, S., Wilm, M., Muir, T. W., & Müller, J. (2010) · Nature · doi:10.1038/nature08966 · Cited by 792
Germline mutations in BAP1 predispose to melanocytic tumors
Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., Windpassinger, C., Wackernagel, W., Loy, S., Wolf, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.910 · Cited by 725
Self-citationJensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Bott, M., Brevet, M., Taylor, B. S., Shimizu, S., Ito, T., Wang, L., Creaney, J., Lake, R. A., Zakowski, M. F., Reva, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.855 · Cited by 717
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
Gelsi‐Boyer, V., Trouplin, V., Adélaïde, J., Bonansea, J., Cervera, N., Carbuccia, N., Lagarde, A., Prebet, T., Nezri, M., Sainty, D., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07697.x · Cited by 564
Abdel-Rahman, M. H., Pilarski, R., Cebulla, C. M., Massengill, J. B., Christopher, B. N., Boru, G., Hovland, P., & Davidorf, F. H. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100156 · Cited by 487
Mutations and Copy Number Increase of HRAS in Spitz Nevi with Distinctive Histopathological Features
Bastian, B. C., LeBoit, P. E., & Pinkel, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64609-3 · Cited by 455
Barnhill, R. L., Argenyi, Z. B., From, L., Glass, L. F., Maize, J. C., Mihm, M. C., Rabkin, M. S., Ronan, S. G., White, W. L., & Piepkorn, M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90193-4 · Cited by 426
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Tan, J., Cang, S., Ma, Y., Petrillo, R. L., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-5 · Cited by 425
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Dey, A., Seshasayee, D., Noubade, R., French, D. M., Liu, J., Chaurushiya, M. S., Kirkpatrick, D. S., Pham, V. C., Lill, J. R., Bakalarski, C. E., et al. (2012) · Science · doi:10.1126/science.1221711 · Cited by 412
O'Hagan, H. M., Mohammad, H. P., & Baylin, S. B. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000155 · Cited by 386
Malignant mesothelioma: Facts, Myths, and Hypotheses
Carbone, M., Ly, B. H., Dodson, R. F., Pagano, I., Morris, P. T., Dogan, U. A., Gazdar, A. F., Pass, H. I., & Yang, H. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22724 · Cited by 376
Ventii, K. H., Devi, N. S., Friedrich, K. L., Chernova, T. A., Tighiouart, M., Van Meir, E. G., & Wilkinson, K. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0365 · Cited by 334
Guo, G., Gui, Y., Gao, S., Tang, A., Hu, X., Huang, Y., Jia, W., Li, Z., He, M., Sun, L., et al. (2012) · Nature Genetics · doi:10.1038/ng.1014 · Cited by 326
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. A., Flores, E. G., Gaudino, G., Powers, A., Bryant-Greenwood, P., Krausz, T., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-179 · Cited by 323
Zhu, P., Zhou, W., Wang, J., Puc, J., Ohgi, K. A., Erdjument-Bromage, H., Tempst, P., Glass, C. K., & Rosenfeld, M. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.024 · Cited by 321
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M. (2006) · Genes & Development · doi:10.1101/gad.1381306 · Cited by 308
Long, G. V., Wilmott, J. S., Capper, D., Preusser, M., Zhang, Y. E., Thompson, J. F., Kefford, R. F., von Deimling, A., & Scolyer, R. A. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826485c0 · Cited by 298
Self-citationHistone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Landreville, S., Agapova, O. A., Matatall, K. A., Kneass, Z. T., Onken, M. D., Lee, R. S., Bowcock, A. M., & Harbour, J. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0946 · Cited by 289
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
Mallery, D. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf691 · Cited by 282
Wiesner, T., Murali, R., Fried, I., Cerroni, L., Busam, K., Kutzner, H., & Bastian, B. C. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182498be5 · Cited by 279
Self-citationThe deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1
Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., & Dutta, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046755 · Cited by 274
Yu, H., Mashtalir, N., Daou, S., Hammond-Martel, I., Ross, J., Sui, G., Hart, G. W., Rauscher, F. J., Drobetsky, E., Milot, E., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00396-10 · Cited by 270
Boultwood, J., Perry, J., Pellagatti, A., Fernandez-Mercado, M., Fernandez-Santamaria, C., Calasanz, M. J., Larrayoz, M. J., Garcia-Delgado, M., Giagounidis, A., Malcovati, L., et al. (2010) · Leukemia · doi:10.1038/leu.2010.20 · Cited by 264
Njauw, C.-N. J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A. M., DeAngelis, M. M., Gragoudas, E., Duncan, L. M., & Tsao, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035295 · Cited by 254
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
Carbone, M., Emri, S., Dogan, A. U., Steele, I., Tuncer, M., Pass, H. I., & Baris, Y. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2068 · Cited by 253
Tyagi, S., Chabes, A. L., Wysocka, J., & Herr, W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.030 · Cited by 249
Duns, G., van den Berg, E., van Duivenbode, I., Osinga, J., Hollema, H., Hofstra, R. M. W., & Kok, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0120 · Cited by 239
BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
Nishikawa, H., Wu, W., Koike, A., Kojima, R., Gomi, H., Fukuda, M., & Ohta, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3355 · Cited by 221
Melanocytic Tumors of Uncertain Malignant Potential
Cerroni, L., Barnhill, R. L., Elder, D. E., Gottlieb, G. J., Heenan, P. J., Kutzner, H., LeBoit, P. E., Mihm, M. C., Rosaí, J., & Kerl, H. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf7fa0 · Cited by 220
Misaghi, S., Ottosen, S., Izrael-Tomasevic, A., Arnott, D., Lamkanfi, M., Lee, J., Liu, J., O'Rourke, K., Dixit, V. M., & Wilson, A. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01517-08 · Cited by 212
Ludgate, M. W., Fullen, D. R., Lee, J., Lowe, L., Bradford, C., Geiger, J., Schwartz, J., & Johnson, T. M. (2009) · Cancer · doi:10.1002/cncr.24047 · Cited by 195
Fan, T., Jiang, S., Chung, N., Alikhan, A., Ni, C., Lee, C.-C. R., & Hornyak, T. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0511 · Cited by 193
Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16 INK4a
Guney, I., Wu, S., & Sedivy, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600069103 · Cited by 180
Frequent inactivation of the BAP1 gene in epithelioid‐type malignant mesothelioma
Yoshikawa, Y., Sato, A., Tsujimura, T., Emi, M., Morinaga, T., Fukuoka, K., Yamada, S., Murakami, A., Kondo, N., Matsumoto, S., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02223.x · Cited by 179
Taguchi, T., Jhanwar, S., Siegfried, J. M., Keller, S. M., & Testa, J. R. (1993) · PubMed · Cited by 166
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen
Mendes‐Pereira, A. M., Sims, D., Dexter, T., Fenwick, K., Assiotis, I., Kozarewa, I., Mitsopoulos, C., Hakas, J., Zvelebil, M., Lord, C. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018872108 · Cited by 138
BMI1 as a novel target for drug discovery in cancer
Cao, L., Bombard, J., Cintron, K., Sheedy, J., Weetall, M. L., & Davis, T. W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23234 · Cited by 137
Reynolds, P. A., Sigaroudinia, M., Zardo, G., Wilson, M. B., Benton, G. M., Miller, C. J., Hong, C., Fridlyand, J., Costello, J., & Tlsty, T. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604175200 · Cited by 137
Narayanan, A., Ruyechan, W. T., & Kristie, T. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704351104 · Cited by 136
COSMIC: the catalogue of somatic mutations in cancer
Bindal, N., Forbes, S. A., Beare, D. M., Gunasekaran, P., Leung, K., Kok, C. Y., Jia, M., Bamford, S., Cole, C. G., Ward, S. A., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-s1-p3 · Cited by 133
An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression
Eletr, Z. M., & Wilkinson, K. D. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9184-6 · Cited by 133
A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma
Wadt, K., Choi, J., Chung, J., Kiilgaard, J. F., Heegaard, S., Drzewiecki, K. T., Trent, J. M., Hewitt, S. M., Hayward, N. K., Gerdes, A., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12006 · Cited by 116
Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
Kemp, C. D., Rao, M., Xi, S., Inchauste, S. M., Mani, H., Fetsch, P. A., Filie, A. C., Zhang, M. F., Hong, J. A., Walker, R. L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0962 · Cited by 101
Toward an Improved Definition of the Tumor Spectrum Associated With BAP1 Germline Mutations
Wiesner, T., Fried, I., Ulz, P., Stacher, E., Popper, H., Murali, R., Kutzner, H., Lax, S., Smolle-Jüttner, F., Geigl, J. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.2965 · Cited by 101
Self-citationControl of α-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities
Kristie, T. M., Liang, Y., & Vogel, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.003 · Cited by 91
Ladanyi, M., Zauderer, M. G., Krug, L. M., Ito, T., McMillan, R. R., Bott, M. J., & Giancotti, F. G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2375 · Cited by 91
Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
Wang, E., Bhattacharyya, S., Szabolcs, A., Rodriguez‐Aguayo, C., Jennings, N. B., Lopez‐Berestein, G., Mukherjee, P., Sood, A. K., & Bhattacharya, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017918 · Cited by 85
Duns, G., Hofstra, R. M. W., Sietzema, J. G., Hollema, H., van Duivenbode, I., Kuik, A., Giezen, C., Osinga, J., de Boer-Bergsma, J. J., Bijnen, H., et al. (2012) · Human Mutation · doi:10.1002/humu.22090 · Cited by 83
Silva, J., García, J. M., Peña, C., García‐Barberán, V., Domínguez, G., Suárez, D., Camacho, F. I., Espinosa, R., Provencio, M., España, P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0788 · Cited by 83
Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death
LIU, L.-M., Andrews, L. G., & Tollefsbol, T. O. (2006) · Oncogene · doi:10.1038/sj.onc.1209454 · Cited by 82
Rocca, A., Minucci, S., Tosti, G., Croci, D., Contegno, F., Ballarini, M., Nolè, F., Munzone, E., Salmaggi, A., Goldhirsch, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604817 · Cited by 79
The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors
Bommi, P. V., Dimri, M., Sahasrabuddhe, A. A., Khandekar, J. D., & Dimri, G. P. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12147 · Cited by 73
Gieni, R. S., Ismail, I. H., Campbell, S., & Hendzel, M. J. (2011) · Cell Cycle · doi:10.4161/cc.10.6.14907 · Cited by 71
Angeloni, D. (2007) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elm007 · Cited by 71
The T1796A mutation of the BRAF gene is absent in Spitz nevi
Palmedo, G., Hantschke, M., Rütten, A., Mentzel, T., Hügel, H., Flaig, M. J., Yazdi, A. S., Sander, C. A., & Kutzner, H. (2004) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2003.00179.x · Cited by 67
Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing
Negishi, M., Saraya, A., Miyagi, S., Nagao, K., Inagaki, Y., Nishikawa, M., Tajima, S., Koseki, H., Tsuda, H., Takasaki, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.166 · Cited by 66
Scolyer, R., Zhuang, L., Palmer, A., Thompson, J. F., & McCarthy, S. (2004) · Pathology (Sydney) · doi:10.1080/00313020412331283879 · Cited by 61
Self-citationLack of BRAF Mutations in Spitz nevi
Gill, M., Renwick, N. M., Silvers, D. N., & Celebi, J. T. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22530.x · Cited by 58
COSMIC (Catalogue of Somatic Mutations in Cancer)
Griffith, M., & Griffith, O. L. (2004) · Wiley eBooks · doi:10.1002/9780471650126.dob0851 · Cited by 56
Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma
Mihic‐Probst, D., Perren, A. A., Schmid, S., Saremaslani, P., Komminoth, P., & Heitz, P. U. (2004) · PubMed · doi:10.5167/uzh-111579 · Cited by 53
Buchhagen, D. L., Qiu, L., & Etkind, P. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570406 · Cited by 51
BRCAs, I., Guénard, F., Labrie, Y., Ouellette, G., Beauparlant, C. J., & Durocher, F. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.6 · Cited by 48
Yong, A. S. M., Stephens, N., Weber, G., Yixin, L. I., Savani, B. N., Eniafe, R. B., Keyvanfar, K., Kurlander, R. J., Rezvani, K., & Barrett, A. J. (2011) · Leukemia · doi:10.1038/leu.2010.325 · Cited by 31
Coupier, I., Cousin, P.-Y., Hughes, D. J., Legoix-Né, P., Trehin, A., Sinilnikova, O. M., & Stoppa‐Lyonnet, D. (2005) · Familial Cancer · doi:10.1007/s10689-005-2833-4 · Cited by 26
Je, E. M., Lee, S. H., & Yoo, N. J. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02909.x · Cited by 16
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
Guidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Jiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Guidelines of care for the management of primary cutaneous melanoma
Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Foote Hood, A., Grichnik, J. M., Swetter, S. M., Tsao, H., Barbosa, V. H., Chuang, T.-Y., Duvic, M., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.031 · Cited by 616
Metadata
- Authors
- Murali, R., Wiesner, T., & Scolyer, R. A.
- Venue
- Pathology
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 45
- Issue
- 2
- Pages
- 116-126
- ISSN
- 0031-3025 (ISSN-L)
- OpenAlex
- W2020216122
- Cited by
- 270
- References
- 82
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.